How many clinical trials are tracked of interferon beta-1a?

13 trials are tracked, 6 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Urology Dermatology Ophthalmology Emergency Medicine Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

interferon beta-1a

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of interferon beta-1a

13 trials tracked of interferon beta-1a: 9 in phase 3 or 4 and 6 with published results. The most-cited published study has 308 citations.

13Trials tracked

9Phase 3 & 4

0Recruiting

6With published results

Phase distribution

Phase 4 1 Phase 3 8 Phase 2 2 Phase 1 2

Phase 3 Adaptive COVID-19 Treatment Trial 3 (ACTT-3) Completed · 308 cited
Phase 3 Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) Completed · 286 cited
Phase 3 Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis Completed · 279 cited
Phase 3 Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis Completed · 45 cited
Phase 3 A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis Completed · 14 cited
Phase 3 A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis Completed · 13 cited

Show 7 more trials

Phase 4 Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients Completed
Phase 3 Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two Completed
Phase 3 Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One Completed
Phase 2 A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease Completed
Phase 2 A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis Completed
Phase 1 Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products Completed
Phase 1 Pharmacokinetics and Pharmacodynamics Study of BCD-033 Compared to Rebif® in Healthy Volunteers Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.